Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Clinical trial NCT00117429 · COMPLETED
Trial details
- NCT number
- NCT00117429
- Sponsor
- Marcus Altfeld, M.D., Ph.D.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.